Mottaghi, P. (2013). Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala). Medknow Publications & Media Pvt Ltd.
Chicago-stil citatMottaghi, Peyman. Changes in Bone Biological Markers After Treatment of Iranian Diabetic Patients With Pioglitazone: No Relation to Polymorphism of PPAR-γ (Pro12Ala). Medknow Publications & Media Pvt Ltd, 2013.
MLA-referensMottaghi, Peyman. Changes in Bone Biological Markers After Treatment of Iranian Diabetic Patients With Pioglitazone: No Relation to Polymorphism of PPAR-γ (Pro12Ala). Medknow Publications & Media Pvt Ltd, 2013.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.